Basal Cell Epithelioma2

  • Upload
    bonggoi

  • View
    227

  • Download
    0

Embed Size (px)

Citation preview

  • 8/4/2019 Basal Cell Epithelioma2

    1/16

    A slow- growing, destructive skin tumor,basal cell epithelioma or carcinoma usuallyoccurs in persons older than age-40; itsmore prevalent in blond, fair skinned menand is most common malignant tumor

    affecting white.

  • 8/4/2019 Basal Cell Epithelioma2

    2/16

    Changes in Epidermal basal cells candiminish maturation andkeratinization.Continuing division of basalcells leads to mass formation. The threetypes are nodular ulcerative lesion,superficial basal cell epithelioma and

    sclerosing basal cell epithelioma.

  • 8/4/2019 Basal Cell Epithelioma2

    3/16

    Arsenic ingestionBurnsImmunosuppressionProlonged sun exposure ( most common)Radiation exposureVaccination (rare)

  • 8/4/2019 Basal Cell Epithelioma2

    4/16

    Occur most commonly on the face,particularly the forehead, eyelid marginsand nasolabial folds.early lesions: small, smooth, pinkish, andtranslucent papules; telangiectatic vesselcrossing the surface; occasionally

    pigmented.later lesions: center depressed; bordersfirm and elevated.

  • 8/4/2019 Basal Cell Epithelioma2

    5/16

    Results in ulceration and local invasion (known as rodent ulcers; rarely metastasizebut if untreated , can spread to vital areasand become infected; can cause massivehemorrhage if they invade large bloodvessels).

  • 8/4/2019 Basal Cell Epithelioma2

    6/16

    Numerous; commonly on chest and back.Oval or irregularly shaped, lightly pigmented

    plaques, with sharply defined, sligthly

    elevated threadlike borders.Appears scaly with small atrophic areas incenter that resembles psoriasis or eczema;usually chronic, but dont tent to invade other

    areas.Related to ingestion of or exposure to arsenic

    containing compunds.

  • 8/4/2019 Basal Cell Epithelioma2

    7/16

    Irradiation is used if the tumor location requires it orif the patient is elderly or debilitaded and might notwithstand surgery.

    Cryotherapy with liquid nitrogen freezes and kills thecells.

    Chemosurgey may be necessary for persistent orrecurrent lesions. Chemosurgery consist ofperiodic applications of a fixative paste (such as

    zinc chloride) and subsequent removal of fixedpathologic tissue. Treatment continues until thetumor has been completely removed.

  • 8/4/2019 Basal Cell Epithelioma2

    8/16

    Instruct the patiet to eat small frequent smallmeals that are high in protein. Suggesteggnog, pureed foods, or liquid protein

    supplement if the lesins has invaded the oralcavity and is causing eating problems.Tell the patient to prevent the disease from

    recurring, he needs to avoid excessive sun

    exposure and use a strong sunscreen orsunshade to protect his skin from damage byultraviolet rays.

  • 8/4/2019 Basal Cell Epithelioma2

    9/16

    Advise patient to relieve local inflammationfrom tropical flourouracil with coolcompresses or corticosteriod ointment.

    Advise patient with noduloulcerative basalcell epithelioma to wash his face gentlywhen ulcerations and crusting occur;

    scrubbing too vigorously may causebleeding.

  • 8/4/2019 Basal Cell Epithelioma2

    10/16

    Waxy, sclerotic, yellow to white plaqueswithout distinct borbers occuring on thehead and the neck that looks like smallpatches of scleroderma.

  • 8/4/2019 Basal Cell Epithelioma2

    11/16

    Incisional or excisional biopsy and histologicstudy may help to determine the tumortype and histologic subtype.

  • 8/4/2019 Basal Cell Epithelioma2

    12/16

    Curettage and electrodesiccation offer goodcosmetic results for small lesions.

    Tropical Flourouracil is commonly use for

    superficial lesions. This medicationproduces mark irritation or inflammation inthe evolved tissue but no systemic effects

    Microscopicalltrolled surgical excisioncarefully removes recurrent lesions, skingrafting may be required.

  • 8/4/2019 Basal Cell Epithelioma2

    13/16

  • 8/4/2019 Basal Cell Epithelioma2

    14/16

    and calorieintake.

    Promote earlymobility.Provideposition

    changes

    Teach patientto practiceaseptictechnique forcleansing,

    medicatinglesions.

    Teach patientthe importanceof need foradequatenutritional food

    intake.

    Advise patientto avoid directsun exposureof affectedarea.

    to promotewellness

    measure topromotewellness.

    n : 107

    Hematocrit0.29

    Segmenters: 0.72

    Lymphocytes: 0.19

    Creatinine:135

  • 8/4/2019 Basal Cell Epithelioma2

    15/16

    CUES/NDXprovidepositionchanges

    GOAL OFOBJECTIVE

    NURSINGINTERVENTION

    RATIONALE

    IMPLEMENTATION

    EVALUATION

    SUBJECTIVE::may sugat sabukol ni inahobjective:LesionImflammedneck

    particularlyaround theaffected area.Poor skinturgor.On ngtfeeding.Dry lips

    At the endof healthteachingclent will beable to:1. verbalize

    understanding ofrecencondition

    2. Identify itsnature andcomplication.3.utilizetreatment canbe done.

    encourageclient toexpressthought freely.

    To advise thepatient to

    follow doctorsorderreligiously.

    Assist patientin comfortableposition.

    Inspectwounds daily

    to identifycausative factors.

    To promotecontinous

    healing andassess thedegree ofimpairment.

    To avoidaspiration andminimize

    Impairmentpromote

    Helpedclientexpressedthoughtsandfeelings.

    Administered NGTfeeding.

    Advised toregiously

    Patienthaveverbalizedrecentconditionfreely.

    Client haveidentifiedpreventivemeasuresfor causinginfection.

  • 8/4/2019 Basal Cell Epithelioma2

    16/16

    NAME OFDRUG

    MECHANISMOF ACTION

    INDICATION/CONTAINDICATION

    SIDEEFFECTS

    NURSINGRESPONSIBILITIES

    Brand name:

    Genericname:Co amoxiclav

    Classification:anti bacterial /anti biotic

    Dosage:1.2mgs

    Route:Intravenous

    An AntibioticIn the class of

    Drugs calledPinicillin itfights bacteriastapinfections itpreventbacterial cellwall synthesisduringreplication

    Used primarilyfor the

    treatmentOf infectiondue tobacterialagentinfections ofthe respiratorytractSkin structure,paranasalsinuses, otitismedia,sinusitis or

    Dizziness,fatigue

    ,insomnia skinrashes, itchyeyes, fine ordry mouth,abnormaltastesensation,diarrhea,rectalbleeding

    AdvanceEffect :

    Always the 10rigths. Rights

    of patient,drugs,dosage,route,frequency

    Advised pt. toReportimmediatelyany unusalmanifestationof the adverseeffect after